Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists

The receptor model-supported design, synthesis and multi-parameter optimization of novel quinazoline derivatives as MCHR1 antagonists are described. The in vivo proof of principle for weight loss is exemplified with compound 42 from this series.